Investigation & Intelligence Feeds
Italy’s AI Law: A National Framework Bounded by the EU AI Act
On October 10, 2025, Italy became the first EU member state to enact comprehensive national AI legislation when Law No. 132/2025 entere...
AI Arbitrators Will Destroy the Legal Profession (And That’s a Good Thing)
Last week, the American Arbitration Association announced something that should have every lawyer cheering: an AI-powered arbitrator fo...
Is Your Slow Website Costing You AI-Generated Client Referrals?
Picture this: It’s Tuesday afternoon, and somewhere in your city, a potential client is sitting on their couch with a problem your law ...
Produce the Requested Databases in Their Native Format, Says Court: eDiscovery Case Law
In the case In re Concho Res., Inc. Sec. Litig., Texas District Judge Andrew S. Hanen, finding that “the limited access to the ARIES da...
Weekly Blockchain Blog – November 2025 #2
US Digital Asset Companies Announce Stablecoin Initiatives, TradFi Integrations - On Nov. 5, Ripple, a U.S. fintech and digital asset...
The Cyber Resilience Act is Rewriting the Rules of Digital Products Safety
The EU Cyber Resilience Act (Regulation (EU) 2024/2847) ("CRA") establishes mandatory cybersecurity requirements for products with digi...
AI News Roundup – US maintains export ban on Nvidia’s advanced AI chips, new research measures scope of AI-induced “brain rot,” EU mulls changes to AI regulations, and more
To help you stay on top of the latest news, our AI practice group has compiled a roundup of the developments we are following....By: Mc...
California DFPI orders restitution and penalties for crypto ATM operator over alleged Digital Financial Assets Law violations
On October 30, the California DFPI announced a consent order with a digital asset kiosk operator, resolving findings that the company v...
FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs in New Draft Guidance
On October 29, 2025, the FDA released a new draft guidance “Scientific Considerations in Demonstrating Biosimilarity to a Reference Pro...
Amgen Files BPCIA Complaints Against Dr. Reddy’s/Alvotech and Amneal Regarding Denosumab Biosimilars
On November 6, 2025, Amgen, Inc. (“Amgen”) launched a new round of BPCIA denosumab litigations when it filed two cases in the U.S. Dist...